{"url_path":"/sec/vani/8-k/2026-06-04/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-000974-index.html","accession_number":"0001753926-26-000974","cik":"0001266806","ticker":"VANI","issuer_name":"Vivani Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-000974-index.html","primary_entity_key":"0001266806","primary_entity_name":"Vivani Medical, Inc."},"word_count":207,"has_tables":true,"body_markdown":"Item 7.01. Regulation FD Disclosure. \n\nVivani Medical, Inc., or Vivani, will make a presentation at the Jefferies Global Healthcare Conference in New York on Thursday, June 4, 2026 at 11:05 a.m. Eastern. A copy of a slide presentation that Dr. Adam Mendelsohn, Vivani’s Chief Executive Officer intends to use during the conference is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein. Vivani is also posting to the “Investors” portion of its website a copy of the slide presentation. The slide presentation speaks only as of the date of this Current Report on Form 8-K. While Vivani may elect to update the slide presentation in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, Vivani specifically disclaims any obligation to do so.\n\nThe information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by reference in such a filing."}